Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Eli Muchtar, Morie A Gertz, Betsy Laplant, Francis K. Buadi, Nelson Leung, Stephanie M. Peterson, P. Leif Bergsagel, Amie Fonder, Yi L. Hwa, Miriam A. Hobbs, Dania Kaehlyn Helgeson, Alanna M. Vossen, Wilson I Gonsalves, Martha Q. Lacy, Prashant Kapoor, Mustaqeem A. Siddiqui, Jeremy Larsen, Rahma M Warsame, Suzanne R. Hayman, Ronald S. Go, David Dingli, Taxiarchis Kourelis, Angela Dispenzieri, S. Vincent Rajkumar, Shaji K. Kumar
Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3096238341